Cite
HARVARD Citation
Cortes, J. et al. (2019). Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial. Lancet oncology. 20 (7), pp. 984-997. [Online].